Ye Liyan, Guan Linbo, Fan Ping, Liu Xinghui, Liu Rui, Chen Jinxin, Zhu Yue, Wei Xin, Liu Yu, Bai Huai
Laboratory of Genetic Disease and Perinatal Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041 China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017 Feb 10;34(1):45-49. doi: 10.3760/cma.j.issn.1003-9406.2017.01.010.
To investigate the relationship between polymorphisms of the growth arrest specific 6 (GAS6) gene and severe preeclampsia in a South West Han Chinese population.
Blood samples from 167 patients with severe preeclampsia and 312 normal pregnant women as controls from Han Chinese in Chengdu area were analyzed by polymerase chain reaction-restriction fragment length polymorphisms.
C and T allele frequencies for +1332C/T site were 85.63% and 14.37% in the patient group, respectively, and 78.04% and 21.96% in control group, respectively. The TT genotype and variant T allelic frequencies of the +1332C/T polymorphism were significantly lower in patients with severe preeclampsia than in the control group (both P<0.05), and the odds ratio for the risk of severe preeclampsia was 0.602 (95%CI: 0.401-0.904) in carriers for the variant T allele (χ=6.045, P=0.014). G and A allele frequencies for 834+7G/A site were 72.75% and 27.25% in case group, respectively, and 74.36% and 25.64% in control group, respectively. The genotype and allele frequencies of the 834+7G/A polymorphism in patients with severe preeclampsia and controls showed no significant differences (both P>0.05). In addition, there was no significant association between the polymorphisms and blood pressure levels in the patient or control groups.
The variant GAS6+1332 T allele is associated with a decreased risk for severe preeclampsia in a South West Han Chinese population. On the other hand, the 834+7G/A polymorphism has no effect on the severe preeclampsia.
探讨生长抑制特异性蛋白6(GAS6)基因多态性与中国西南地区汉族人群重度子痫前期的关系。
采用聚合酶链反应-限制性片段长度多态性方法,对成都地区167例重度子痫前期患者及312例正常孕妇(作为对照)的血样进行分析。
重度子痫前期患者组+1332C/T位点的C和T等位基因频率分别为85.63%和14.37%,对照组分别为78.04%和21.96%。重度子痫前期患者中+1332C/T多态性的TT基因型和变异T等位基因频率显著低于对照组(均P<0.05),变异T等位基因携带者发生重度子痫前期的风险比为0.602(95%CI:0.401-0.904)(χ=6.045,P=0.014)。病例组834+7G/A位点的G和A等位基因频率分别为72.75%和27.25%,对照组分别为74.36%和25.64%。重度子痫前期患者与对照组834+7G/A多态性的基因型和等位基因频率无显著差异(均P>0.05)。此外,多态性与患者组或对照组的血压水平无显著关联。
在中国西南地区汉族人群中,变异的GAS6 +1332 T等位基因与重度子痫前期风险降低有关。另一方面,834+7G/A多态性对重度子痫前期无影响。